Optimal Asset Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-2,561,233
Closed -$409K 353
2021
Q1
$409K Sell
2,561,233
-1,600
-0.1% -$515K 0.05% 313
2020
Q4
$877K Sell
2,562,833
-2,218,006
-46% -$681M 0.12% 255
2020
Q3
$667K Buy
4,780,839
+4,777,427
+140,018% +$1.29B 0.1% 299
2020
Q2
$897K Sell
3,412
-5,800
-63% -$1.55M 0.15% 229
2020
Q1
$2.09K Buy
9,212
+4,063
+79% +$1.11M 0.2% 180
2019
Q4
$1.55M Buy
+5,149
New +$1.42M 0.24% 166

Other funds holding ELV

Optimal Asset Management's ELV Position: Q2 2021 in Review

Optimal Asset Management sold out of Elevance Health (ELV) in Q2 2021, closing a stake of 2,561,233 shares — an estimated $409K sold.

Optimal Asset Management first reported a position in ELV in Q4 2019 and held it in 6 quarters. The position peaked at $1.55M in Q4 2019. 1,234 funds tracked by Wall St. Rank hold ELV as of Q2 2021.

  • Optimal Asset Management reported no remaining Elevance Health position as of Q2 2021 after selling out during the quarter.
  • Optimal Asset Management sold 2,561,233 Elevance Health shares in Q2 2021, an estimated $409K.
  • Optimal Asset Management first reported a position in Elevance Health in Q4 2019 and held it in 6 quarters.
  • Optimal Asset Management's Elevance Health position peaked at $1.55M in Q4 2019.
  • 1,234 funds tracked by Wall St. Rank held Elevance Health as of Q2 2021.

Based on Optimal Asset Management's 13F filing for Q2 2021, filed 16 Aug 2021.